Edesa Biotech, Inc.EDSANASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank77
3Y CAGR+107.8%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+107.8%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
9x
Strong expansion
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 7.68% |
| Q3 2025 | -7.72% |
| Q2 2025 | -10.02% |
| Q1 2025 | 295.14% |
| Q4 2024 | 9.18% |
| Q3 2024 | -27.04% |
| Q2 2024 | -19.26% |
| Q1 2024 | -17.32% |
| Q4 2023 | -11.91% |
| Q3 2023 | -5.62% |
| Q2 2023 | -11.75% |
| Q1 2023 | -8.58% |
| Q4 2022 | 0.86% |
| Q3 2022 | -34.01% |
| Q2 2022 | -14.05% |
| Q1 2022 | 65.33% |
| Q4 2021 | -15.37% |
| Q3 2021 | -13.58% |
| Q2 2021 | -29.68% |
| Q1 2021 | 133.24% |
| Q4 2020 | -4.38% |
| Q3 2020 | 20.62% |
| Q2 2020 | 16.90% |
| Q1 2020 | 49.97% |
| Q4 2019 | -10.99% |
| Q3 2019 | -20.89% |
| Q2 2019 | -21.02% |
| Q1 2019 | -12.85% |
| Q4 2018 | -10.87% |
| Q3 2018 | -7.98% |
| Q2 2018 | 140.19% |
| Q1 2018 | -19.17% |
| Q4 2017 | -14.59% |
| Q3 2017 | -14.43% |
| Q2 2017 | -11.75% |
| Q1 2017 | -10.85% |
| Q4 2016 | -11.37% |
| Q3 2016 | 52.21% |
| Q2 2016 | -9.85% |
| Q1 2016 | -8.94% |